Author

Manasa P. Srikanth

Observed name: Manasa P Srikanth

Institution: University of Maryland, Baltimore

Observed institution: University of Maryland, Baltimore

ORCID: 0000-0002-9831-4141

Observed ORCID: 0000-0002-9831-4141

OpenAlex ID: A5000272595

mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells

2019 · Robert A. Brown, Antanina Voit, et al. · Disease Models & Mechanisms · 76

Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation

2017 · Ola Awad, Leelamma M. Panicker, et al. · Stem Cell Reports · 51

Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition

2017 · Leelamma M Panicker, Manasa P Srikanth, et al. · Human Molecular Genetics · 49

Elevated Glucosylsphingosine in Gaucher Disease induced Pluripotent Stem Cell Neurons Deregulates Lysosomal Compartment through Mammalian Target of Rapamycin Complex 1

2021 · Manasa P. Srikanth, Jace W. Jones, et al. · Stem Cells Translational Medicine · 42

Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein

2021 · Nicole R. Gould, Katrina M. Williams, et al. · eLife · 39

Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model ofGBA1-associated Parkinson’s disease

2023 · Manoj Kumar, Manasa P Srikanth, et al. · Human Molecular Genetics · 19

Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease

2020 · Manasa P. Srikanth, Ricardo A. Feldman · Biomolecules · 16

Author response: Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein

2021 · Nicole R Gould, Katrina M Williams, et al. · 1

Works count: 8

Citation count: 293

H-index: 7

I10-index: 7